苓桂术甘汤治疗痰饮证的机理及临床研究进展  

Mechanism and Clinical Research Progress of Linggui Zhugan Decoction in the Treatment of Tanyin Phlegm Drink

作　　者：赵丰抗 刘驯 

机构地区：[1]湖北中医药大学第一临床学院,湖北 武汉 [2]湖北中医药大学附属江津中医院,重庆

出　　处：《中医学》2023年第6期1332-1337,共6页Traditional Chinese Medicine

摘　　要：《金匮要略》被后世誉为“方书之祖”,是我国现存最早的杂病专著,对中医学的发展具有深远的影响。痰饮证在西医中多称为心力衰竭、冠心病、慢性支气管炎、慢性胃炎、肾炎水肿等疾病。大量研究表明苓桂术甘汤药理机制明确,治疗相关疾病临床疗效明显。本文通过整合近些年苓桂术甘汤治疗痰饮证的中医机理和现代药理研究,以及苓桂术甘汤与其他药物合治痰饮证的临床疗效观察,以期该方药更好地服务于临床,提高痰饮证疾病的治愈率。The “Synopsis of the Golden Chamber” is known as the “ancestor of prescription books” in later generations, and is the earliest existing monograph on miscellaneous diseases in China. It has important guiding significance for clinical practice to this day. Phlegm yin syndrome is referred to in Western medicine as diseases such as heart failure, coronary heart disease, chronic bronchitis, chronic gastritis and nephritis edema. Numerous studies have shown that the pharmacological mechanism of Linggui Zhugan Decoction is clear, and its clinical efficacy in treating related diseases is significant. This article integrates the traditional Chinese medicine mechanism and modern pharmacological research of Linggui Zhugan Decoction in the treatment of phlegm retention syndrome in recent years, as well as the clinical efficacy observation of Linggui Zhugan Decoction combined with other drugs in the treatment of phlegm retention syndrome, in order to better serve clinical practice and improve the cure rate of phlegm retention syndrome.

关 键 词：苓桂术甘汤 痰饮证 临床研究 机理 综述 

分 类 号：R25[医药卫生—中医内科学]